Indications
Mometasone Furoate + Olopatadine Hydrochloride nasal spray is used to treat the symptoms of seasonal allergic rhinitis. It can be given to adults and to children aged 6 years and older.
⚠️ Always consult a registered physician before taking any medicine.
Pharmacology
This is a metered-dose manual nasal spray containing an aqueous suspension of a fixed-dose combination of olopatadine hydrochloride and mometasone furoate monohydrate.
Olopatadine is a histamine-1 (H1) receptor inhibitor. Its antihistamine activity has been documented in isolated tissues, animal models and humans.
Mometasone furoate is a corticosteroid with potent anti-inflammatory activity. The precise way corticosteroids act in allergic rhinitis is not known. They have been shown to have a wide range of inhibitory effects on many cell types (for example mast cells, eosinophils, neutrophils, macrophages and lymphocytes) and on mediators involved in inflammation (for example histamine, eicosanoids, leukotrienes and cytokines).
Pregnancy & Breastfeeding
We don't have any data on the use of mometasone furoate in pregnant women, so it isn't known whether it carries a risk of major birth defects, miscarriage or other harmful outcomes for the mother or the baby. There are also no data on whether olopatadine or mometasone furoate, or its metabolites, pass into human milk. The effects on a breastfed child and on milk production are likewise unknown. Other corticosteroids similar to mometasone furoate are excreted in human milk. However, plasma concentrations of mometasone furoate after nasal therapeutic doses are low, so the concentrations in breast milk are likely to be correspondingly low.
⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
Dosage Reference
⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.
Side Effects & Interactions
Side Effects
No side-effect data recorded yet.